Large-scale testing (Phase 3)Active Not RecruitingNCT05527704
What this trial is testing
The Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
Who this might be right for
TTNRespiratory FailurePPHN
Medical University of Warsaw 608